Shape

Change

at Every

Step.

Join us for Clinical Pathways Congress, the meeting that brings together senior leaders throughout the cancer care spectrum to discuss clinical pathways and their impact on improved patient outcomes, quality, and cost measures as the market shifts to a value-based care model. This is the only conference where you'll learn how to implement, integrate, and measure treatment pathways within your institution by asking critical questions, sharing your challenges, and walking away with actionable and immediate strategies for success.

This is your opportunity to shape change at every step along the path to value-based care.

This program is focused on the critical questions surrounding clinical pathways and the opportunities to develop new strategies that address evidence-based care through:

Design

AND TESTING

Implementation

AND EVALUATION

Impact

ON QUALITY OF CARE, COSTS, AND HEALTH OUTCOMES

2017 Participating Organizations Included:

  • Cleveland Clinic

  • Harvard Medical School

  • Cancer Treatment Centers of America

  • Lilly

  • Express Scripts

  • Dana Farber Cancer Institute

  • Pfizer Oncology

  • Moffitt Cancer Center

  • Flatiron Health

  • Eisai

  • McKesson Specialty Health

  • Roswell Park Cancer Institute

  • Thomas Jefferson University Hospital

  • Janssen Biotech

  • Knight Cancer Institute

  • Stanford University Medical Center

  • Genentech

  • AmerisourceBergen

  • Maryland Oncology Hematology

  • NYU Langone Medical Center

  • Seattle Cancer Care Alliance

  • Evicore Healthcare

Highlights

Shape

your knowledge of clinical pathways–the program features sessions addressing pathway design, testing, implementation, standards, measurement, and evaluation.

Share

ideas, concerns, challenges, discoveries, and success stories with a community of multidisciplinary stakeholders.

Shed

misconceptions you may have about pathways by connecting with leading faculty with expertise of how to ensure pathways are safe, effective, and evidence-based.

Steering Committee

Alan Balch
PhD

Chief Executive Officer

Patient Advocate Foundation

Hampton, Virginia

Aymen Elfiky
MD, MSc, MBA

Instructor of Medicine

Harvard Medical School

Instructor of Medical Oncology

Dana-Farber Cancer Institute

Boston, Massachusetts

Joan S. McClure
MS

Senior Vice President, Clinical Information and Publications

National Comprehensive Cancer Network (NCCN)

Ft. Washington, Pennsylvania

Sandeep "Bobby" Reddy
MD

Chief Medical Officer

NantHealth

Culver City, California

 

Robin T. Zon
MD, FACP, FASCO

Chair, ASCO Pathways Task Force

Vice President, Finance & Quality Chair

Vice President, Michiana Hematology-Oncology, PC

Mishawaka, Indiana

Keep Me Informed

Contact Us